TACE for the treatment of primary hepatocellular carcinoma associated with portal vein tumor thrombus: recent progress in research
10.3969/j.issn.1008-794X.2017.07.022
- VernacularTitle:TACE治疗原发性肝癌伴门静脉癌栓研究进展
- Author:
Shimeng SUN
;
Yingxing GUO
;
Zhenwu LEI
;
Haojie WANG
- Keywords:
primary hepatocellular carcinoma;
portal vein tumor thrombus;
transcatheter arterial chemoemholization;
interventional therapy
- From:
Journal of Interventional Radiology
2017;26(7):668-671
- CountryChina
- Language:Chinese
-
Abstract:
At present,the combined interventional therapy that is based on transcatheter arterial chemoembolization (TACE) technique can control the progression of primary hepatocellular carcinoma (PHC)in different degrees,at the same time the clinical objectives,such as relieving portal hypertension,eliminating portal vein occlusion,controlling refractory ascites and lowering upper gastrointestinal bleeding probability,can be reliably achieved.Thus,the quality of life of the patients can be effectively improved and the survival time will be reliably prolonged.This paper aims to make a comprehensive review about the medical articles concerning TACE combined with other interventional therapies for PHC complicated by portal vein tumor thrombus,which have been published both at home and abroad in recent years,in order to provide practical help for clinical diagnosis and treatment of PHC.